Review on microparticulate drug delivery system

International Journal of PharmTech Research

Volumn 3, Issue 3, 2011, Pages 1242-1254

  Satheesh Madhav, N V ^a   Kala, Shivani ^a  

^a DIT UNIVERSITY   (India)

Author keywords

Centrifugation; Characterization; Emulsion; Evaluation; Microparticles

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; BACAMPICILLIN; BLEOMYCIN SULFATE; CEFADROXIL; CEFALEXIN; CEFRADINE; CHLORAMPHENICOL; CHLORPROMAZINE; CIPROFLOXACIN; CLARITHROMYCIN; DICLOFENAC; DIPHENHYDRAMINE; DOXORUBICIN; DRUG VEHICLE; ERYTHROMYCIN; LOCAL ANESTHETIC AGENT; MITOMYCIN C; NALTREXONE; OFLOXACIN; OIL IN OIL EMULSION; PHENOBARBITAL; POLYMER; PROMETHAZINE; STEROID; TIMOLOL MALEATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BIOCOMPATIBILITY; COACERVATION; COLLOID; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG RESEARCH; DRUG SCREENING; EMULSION; EMULSION SOLVENT EVAPORATION; EVAPORATION; GELATIN DISPERSION; MICROENCAPSULATION; MICROPARTICULATE DRUG DELIVERY SYSTEM; MULTIPLE EMULSION; PARTICLE SIZE; PHASE SEPARATION; POLYMERIZATION; PRECIPITATION; SPRAY DRYING; STATIC ELECTRICITY; THERMOGRAVIMETRY;

EID: 79961154440     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Lwise Donald, Handbook of Pharmaceutical Controlled Release Technology, New York, 2000; 271. US. Patent WO/2000/O32166 published in April 15, 1999.
2. Deasy PB, Microencapsulation and Related Drug Processes. Marcel Dekker, New York 1984.
3. Khalil SAH, Nixon JR and Carless JE. Role of pH in the coacervation of the systems: gelatine-water- ethanol and gelatine-water- sodium sulphate. J. Pharm Pharmacol., 1968; 20: 215-225.
4. Thies, C. Microencapsulation. In: Encyclopedia of Polymer and Engineering, J. I. Kroschwitz, H. F. Mark, N. M 1987.
5. Sah HK, Toddywala R and Chien YW. Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release. J. Microencap., 1995; 12: 59-69.
6. Crotts G and Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J.Control. Rel., 1995; 35: 91-105.
7. Crotts G, Sah H and Park TG. Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation. J. Control. Rel., 1997; 47: 101-111.
8. Gombotz W R and Pettit DK Biodegradable polymers for protein and peptide drug delivery. Bioconj. Chem., 1995; 6:332-346.
9. Crotts G and Park TG 1998. Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J. Microencap., 15: 699- 713. 91.
10. Okada, H., Yamamota, M., Heya, T., Inoue, Y., Kamei, S., Ogawa, Y., and Toguchi, H., 1994. Drug delivery using biodegradable microspheres. J. Control. Rel., 28: 121-129.
11. Nixon JR, Khalil SAH and Carless JE. Gelatin coacervate microcapsules containing sulphamerazine: their preparation and the in vitro release of drug. J. Pharm. Pharmacol., 1968; 20: 528-538.
12. Khalil SAH, Nixon JR and Carless JE. Role of pH in the coacervation of the systems: gelatine-water- ethanol and gelatine-water- sodium sulphate. J. Pharm Pharmacol., 1968; 20: 215-225.
13. Thies, C. Microencapsulation. In: Encyclopedia of Polymer and Engineering, J. I. Kroschwitz, H. F. Mark, N. M 1987.
14. Komatsu M, Tagawa K, Kawata M and Goto S. Biopharmaceutical evaluation of gelatine microcapsules of sulfonamides. Chem. Pharm. Bull., 1983; 31: 262-268.
15. Nixon JR and Meleka MR, The in vivo performance of theophylline microcapsules, J. Microencap., 1984; 1: 65-72.
16. Goto S, Moriya F, Kawata M and Kimura T, Preparation and biopharmaceutical evaluation of microcapsules of amoxicillin, J. Microencap., 1984; 1: 137-155.
17. Siddiqui O and Taylor H, Physical factors affecting microencapsulation by simple coacervation of gelatine. J. Pharm. Pharmacol., 1983; 35: 70-73.
18. Tagawa K, Kawata M and Goto S, Biopharmaceutical evaluation of gelatine microcapsules of several antibiotics. Chem. Pharm. Bull., 1983; 31: 269-273.
19. Goto S, Komatsu M, Tagawa K and Kawata M, Preparation and evaluation of gelatine microcapsules of sulfonamides. Chem. Pharm. Bull., 1983; 31: 256-261.
20. Madan PL, Jani RK and Bartilucci AJ, New method of preparing gelatine microcapsules of soluble pharmaceuticals. J. Pharm. Sci., 1978; 67: 409-411.
21. Madan PL, Madan DK and Price LC. The effect of pH on the fractionation of gelatine, Can. J. Pharm. Sci., 1976; 11: 21-25.
22. Nixon JR. In vitro and in vivo release of microencapsulated chlorothiazide, Proc. 4th Int. Symp. Microencap., Miami, FL, 1981; 26-28.
23. Nixon JR, In vitro and in vivo release of microencapsulated chlorothiazide, Proc. 4th Int. Symp. Microencap, Miami, FL, 1981; 26-28.
24. Nixon JR and Meleka MR, The preparation and characterisation of ethylcellulose-walled theophylline microcapsules, J. Microencap., 1984; 1: 53-64.
25. Healy AM. School of Pharmacy & Pharmaceutical Sciences, University of Dublin, Trinity College Dublin, Dublin 2, Ireland.
26. Nykamp G. et al. Cingres International Symosium on Microencapsulation No 13, Angers, FRANCE (05/09/2001) 2002; vol 242, no 1-2 415p.
27. Ljudmila Fele Zilnik, et al. Controlled Releae of the Active Ingredient: Mechanisms, Devices & Analysis T3-2P
28. Khalil SAH, Nixon JR and Carless JE. Role of pH in the coacervation of the systems: gelatine-water- ethanol and gelatine-water- sodium sulphate. J. Pharm Pharmacol., 1968; 20: 215-225.
29. Ertan G, Ozer O, Baloglu E and Guneri T, Sustained release microcapsules of nitrofurantion and amoxicillin preparation, in-vitro release rate kinetics and micrometric studies. J. Microencap., 1997; 14: 379-388.
30. Goto S, Moriya F, Kawata M and Kimura T, Preparation and biopharmaceutical evaluation of microcapsules of amoxicillin, J. Microencap, 1984; 1: 137-155.
31. Alpar OH and Walter V, Prolongation of the in vitro dissolution of a soluble drug (phenethicillin potassium) by microencapsulation with ethylcellulose. J. Pharm. Pharmacol., 1981; 33: 419-422.
32. Alpar OH., Sustained-release characteristics of tablets of ethylcellulose microcapsules containing potassium phenethicillin. Il. Pharmaco-Ed. Pr., 1980; 36: 366-373.
33. Lu MF, Borodkin S, Woodward L and Vadnere M, Polymer carrier system for taste masking of macrolide antibiotics. Pharm. Res., 1991; 8: 706-712.
34. Friend D R, Polyacrylate resin microcapsules for taste masking of antibiotics. J. Microencap., 1992; 9: 469-480.
35. Tunçel T, Bergisadi N, Akin L, Otuk G and Kuscu I, In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. Pharmacie, 1996; 51: 168-171.
36. Kristi A, Bogataj M, Mrhar A and Kozjeli F, Preparation and evaluation of ethylcellulose microencapsules with bacampicillin. Drug Dev. Ind. Pharm., 1991; 17: 1109-1130.
37. Ueda M, Nakamura Y, Makita H and Kawashimo Y. One continuous process of agglomeration and microencapsulation for enoxacin. Preparation method and mechanism of microencapsulation. J. Microencap. 1993; 10: 25-34.
38. Jalil R and Nixon J, Microencapsulation with biodegradable materials. In: Microencapsulation of Drugs, 1992; 177-188.
39. Madan PL, Madan DK and Price LC. The effect of pH on the fractionation of gelatine, Can. J. Pharm. Sci., 1976; 11: 21-25.
40. Paradissis GN and Parrot E L. Gelatin encapsulation of pharmaceuticals. J. Clin. Pharmacol. January- February, 54-59.
41. Nixon, J.R. and Walker, S.E., 1971. The in vitro evaluation of gelatine coacervate microcapsules. J. Pharm. Pharmacol., 23 (Suppl.): 1968; 147S-154S.
42. Kondo T. Microcapsules: their preparation and properties. In: Surface and Colloid Science, E. Matijevic (Ed.), Plenum Press, New York, 1978; 1-22
43. Lu MF, Borodkin S, Woodward L and Vadnere M, Polymer carrier system for taste masking of macrolide antibiotics. Pharm. Res., 1991; 8: 706-712.
44. Tunçel T, Bergisadi N, Akin L, Otuk G and Kuscu I, In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. Pharmacie, 1996; 51: 168-171.
45. Kristi A, Bogataj M, Mrhar A and Kozjeli F, Preparation and evaluation of ethylcellulose microencapsules with bacampicillin. Drug Dev. Ind. Pharm., 1991; 17: 1109-1130.
46. Ueda M, Nakamura Y, Makita H and Kawashimo Y. One continuous process of agglomeration and microencapsulation for enoxacin. Preparation method and mechanism of microencapsulation. J. Microencap. 1993; 10: 25-34.
47. Asici S, Özer Ö and Baloglu E, Microcapsules of ciprofloxacin: formulation and in vitro release kinetics. Proc. 9th Int. Symp. On Microencapsulation., Ankara, Turkey, 1993; 34
48. Asici S, Baloglu E and Özer Ö, Studies on ofloxacin microcapsules: microencapsulation and in vitro dissolution kinetics. Proc. 9th Int. Symp. On Microencapsulation. Ankara, Turkey, 1993; 32.
49. Ertan G, Sarigüllü I, Karasulu Y, Kantarci G, and Asikoglu M. A new microcapsule form of ampicillin and amoxycillin. Proc. 9th Int. Symp. on Microencapsulation., Ankara, Turkey, 1993; 56,
50. Genç L, Demirel M, Güler E and Megazy N, Microencapsulation of ketorolac tromethamine by means of a coacervation phase separation technique induced by the addition of non- solvent. J. Microencap, 1998; 15: 45-54.
51. Ueda M, Nakamura Y, Makita H and Kawashima Y, Preparation of microcapsules masking the bitter taste of enoxacin by using one continuous process technique of agglomeration and microencapsulation. J. Microencap., 1993; 10: 461-473.
52. Yu WP, Wong JP, and Chang TM, Preparation of polylactic acid microcapsules containing ciprofloxacin. J. Microencap., 1998; 15: 515-523.
53. Tirkkonen S, Turokka L and Paronen P. Microencapsulation of indomethacin by gelatin-acacia complex coacervation in the presence of surfactants. J. Microencap., 1994; 11: 615-626.
54. Tirkkonen S and Paronen P. Release of indomethacin tabletted ethylcellulose microcapsules. Int. J. Pharm., 1993; 92: 55-62.
55. Burgess D J and Carless JE. Manufacture of gelatine/gelatine coacervate microcapsules, Int. J. Pharm. 1985; 27: 61-70.
56. Juni K, Ogata J, Nakano M, Ichihara T, Mori K, and Akagi M, Preparation and evaluation in vitro and in vivo of poly (lactic acid) microspheres containing doxorubicin. Chem. Pharm. Bull., 1985; 33: 313-318.
57. Crotts G and Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J.Control. Rel., 1995; 35: 91-105.
58. Suzuki K and Price JC. Microencapsulation and dissolution properties of neuroleptic in a biodegradable polymer, poly (D, L-lactide). J. Pharm. Sci., 1985; 74: 21-24.
59. Cha Y and Pitt CG. The acceleration of degradation-controlled drug delivery from polyester microspheres. J. Control. Rel., 1989; 8: 259-265.
60. Goto S, Tsujiyama T, Kawata M and Nobuo S, Preparation and biopharmaceutical evaluation of gelatine microcapsules of pretanide. J. Contr. Rel., 1985; 1: 291-300.
61. Goto S, Moriya F, Kawata M and Kimura T, Preparation and biopharmaceutical evaluation of microcapsules of amoxicillin, J. Microencap, 1984; 1: 137-155.
62. Alpar OH and Walter V, Prolongation of the in vitro dissolution of a soluble drug (phenethicillin potassium) by microencapsulation with ethylcellulose. J. Pharm. Pharmacol., 1981; 33: 419-422.
63. Alpar OH., Sustained-release characteristics of tablets of ethylcellulose microcapsules containing potassium phenethicillin. Il. Pharmaco-Ed. Pr., 1980; 36: 366-373.
64. Juni K, Ogata J, Nakano M, Ichihara T, Mori K, and Akagi M, Preparation and evaluation in vitro and in vivo of poly (lactic acid) microspheres containing doxorubicin. Chem. Pharm. Bull., 1985; 33: 313-318.
65. Jalil R and Nixon J, Microencapsulation with biodegradable materials. In: Microencapsulation of Drugs, Switzerland, 1992; 177-188.
66. Nixon JR. In vitro and in vivo release of microencapsulated chlorothiazide, Proc. 4th Int. Symp. Microencap., Miami, FL, 1981; 26-28.
67. Ozer AY and Hincal AA Studies on the masking of unpleasant taste of beclamide microencapsulation and tabletting, J. Microencap., 1990; 7: 327-339.
68. Tirkkonen S and Paronen P, Release of indomethacin tabletted ethylcellulose microcapsules. Int. J. Pharm., 1993; 92: 55-62.
69. Salib NN, El-Menshawy ME and Ismail AA, Ethyl cellulose as a potential sustained release coating for oral pharmaceuticals. Pharmazie, 1976; 31: 721-723.
70. Tirkkonen S and Paronen P. Release of indomethacin tabletted ethylcellulose microcapsules. Int. J. Pharm., 1993; 92: 55-62.
71. Madan PL, Madan DK and Price LC. The effect of pH on the fractionation of gelatine, Can. J. Pharm. Sci., 1976; 11: 21-25.
72. Paradissis GN and Parrot EL. Gelatin encapsulation of pharmaceuticals. J. Clin. Pharmacol. January- February, 54-59.
73. Ertan G, Ozer O, Baloglu E and Guneri T, Sustained release microcapsules of nitrofurantion and amoxicillin preparation, in-vitro release rate kinetics and micrometric studies. J. Microencap., 1997; 14: 379-388.
74. Paradissis, G.N. and Parrot, E.L. Gelatin encapsulation of pharmaceuticals. J. Clin. Pharmacol. January- February, 1968; 54-59.
75. Nixon, J.R. and Walker, S.E. The in vitro evaluation of gelatine coacervate microcapsules. J. Pharm. Pharmacol., 1971; 23 (Suppl.): 147S-154S.
76. Crotts G and Park TG 1998. Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J. Microencap., 15: 699-713.
77. Okada, H., Yamamota, M., Heya, T., Inoue, Y., Kamei, S., Ogawa, Y., and Toguchi, H., 1994. Drug delivery using biodegradable microspheres. J. Control. Rel., 28: 121-129.
78. Burgess DJ and Carless JE, Microelectrophoretic studies of gelatine and acacia for the prediction of complex coacervation J. Colloid Interf. Sci., 1984; 98:1-8.
79. Mordata SAM, Egaky AME, Motawi AM and Khodery KAE, Preparation of microcapsules from complex coacervation of Gantrez gelatine, I. Development of technique, J. Microencap., 1987; 4: 11-21.
80. Nixon JR, In vitro and in vivo release of microencapsulated chlorothiazide, Proc. 4th Int. Symp. Microencap, Miami, FL, 1981; 26-28.
81. Healy AM. School of Pharmacy & Pharmaceutical Sciences, University of Dublin, Trinity College Dublin, Dublin 2, Ireland.
82. Asici S, Özer Ö and Baloglu E, Microcapsules of ciprofloxacin: formulation and in vitro release kinetics. Proc. 9th Int. Symp. On Microencapsulation., Ankara, Turkey, 1993; 34
83. Asici S, Baloglu E and Özer Ö, Studies on ofloxacin microcapsules: microencapsulation and in vitro dissolution kinetics. Proc. 9th Int. Symp. on Microencapsulation., Ankara, Turkey, 1993; 32.
84. Ertan G, Sarigüllü I, Karasulu Y, Kantarci G, and Asikoglu M. A new microcapsule form of ampicillin and amoxycillin. Proc. 9th Int. Symp. on Microencapsulation., Ankara, Turkey, 1993; 56,
85. Genç L, Demirel M, Güler E and Megazy N, Microencapsulation of ketorolac tromethamine by means of a coacervation phase separation technique induced by the addition of non- solvent. J. Microencap, 1998; 15: 45-54.
86. Ueda M, Nakamura Y, Makita H and Kawashima Y, Preparation of microcapsules masking the bitter taste of enoxacin by using one continuous process technique of agglomeration and microencapsulation. J. Microencap., 1993; 10: 461-473.
87. Das, S.K., Effect of polybutadiene on the encapsulation efficiency of ethylcellulose microcapsules of sulphadiazine. J. Microencap., 1993; 10: 437-447.
88. Lu MF, Borodkin S, Woodward L and Vadnere M, Polymer carrier system for taste masking of macrolide antibiotics. Pharm. Res., 1991; 8: 706-712.
89. Tunçel T, Bergisadi N, Akin L, Otuk G and Kuscu I, In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. Pharmacie, 1996; 51: 168-171.
90. Goto S, Komatsu M, Tagawa K and Kawata M, Preparation and evaluation of gelatine microcapsules of sulfonamides. Chem. Pharm. Bull., 1983; 31: 256-261.
91. Green, B.K., US Patent 2,800,458, July 23, 1957.
92. Freitas MN & Marchetti J.M. Laboratory of Pharmaceutical Technology, Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirao, University of Sao Paulo US Patent 5648095.
93. Suzuki K and Price JC. Microencapsulation and dissolution properties of neuroleptic in a biodegradable polymer, poly (D, L-lactide). J. Pharm. Sci., 1985; 74: 21-24.
94. Cha Y and Pitt CG. The acceleration of degradation-controlled drug delivery from polyester microspheres. J. Control. Rel., 1989; 8: 259-265.
95. Crotts G and Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J.Control. Rel., 1995; 35: 91-105.
96. Ueda M, Nakamura Y, Makita H and Kawashima Y, Preparation of microcapsules masking the bitter taste of enoxacin by using one continuous process technique of agglomeration and microencapsulation. J. Microencap., 1993; 10: 461-473.
97. Bhatnagar S, Nakhare S and Vyas SP. Poloaxamer-coated three-ply-walled microcapsules for controlled delivery of diclofenac sodium. J. Microencap. 1995; 12: 13-22.
98. Meshali MM, El-Dien EZ, Omar SA and Luzzi LA. A new approach to encapsulating nonsteroidal anti-inflammatory drugs. III. Coating acidic as well as basic nonsteroidal anti-inflammatory drugs with cellulose derivatives having different functional groups. J. Microencap., 1989; 6: 339-353.
99. Izgü E. and Doganay T., Determination of microencapsulation conditions of gelatine succinate by coacervation and dissolution rate of sulfisaxoazole from these microcapsules, J. Fac. Pharm., 1976; 6: 54-87.